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 Many beehive products such as propolis, Manuka honey, bee pollen, and royal jelly have 
been used by people due to their popular known health benefits.  A novel bee product, bee 
venom, has demonstrated effective in treating various debilitating conditions, and thus bee 
venom therapy has been the subject of scientific studies to quantify its medical efficacy. 
Although bee venom has been used for millennia in Eastern medicine, modern bee venom 
therapy (BVT) originated in Europe in the 19th century, but was brought to the U.S. by Dr. 
Bodog Beck after World War I. The treatment became more widespread in the West as the 20th 
century progressed (Cooney et al, 2011).  There are currently various application methods with 
the most popular being apipuncture (acupuncture with bee venom where needles are initially 
dipped into the venom before applied to the patient) and bee venom injections (Mohammadi et 
al, 2015).   The multiple beneficial effects of bee venom include increased blood circulation, 
stimulation of the pituitary-cortical system, and reduced pain and inflammation (Mohammadi et 
al, 2015).  These responses help treat the symptoms of many diseases and chronic inflammatory 
conditions. With additional research, the use of bee venom can be included as a means to safely 
alleviate the symptoms of several autoimmune diseases, especially rheumatoid arthritis (RA). 
 Rheumatoid arthritis is a progressive and chronic inflammatory disease that affects the 
joints and deteriorates other systems such as skin, blood vessels, heart, and eyes.  This 
autoimmune disorder causes the body to attack the synovium lining of the joints which causes 
weakening and stretching of the ligaments and tendons surrounding the joints (Woo-Ram et al, 
2009).  As a result, the synovium grows thicker causing the joints to lose their alignment and 
shape.  This is followed by severe inflammation that results in bone erosion causing chronic 
pain. Although the exact trigger of this process is unknown, doctors suspect underlying genetics 
that don’t necessarily cause rheumatoid arthritis but make patients more susceptible to 
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environmental agents such as carcinogens, silica, bacteria and viruses that can trigger it (Deok-
Sang et al, 2015). Symptoms include joint and blood vessel swelling, pain, morning stiffness, 
lumps and discoloration under the skin, dryness in eyes and mouth, anemia, and various others.  
Usually occurring in more than one joint, not limited to any particular joints, Rheumatoid 
Arthritis affects almost 1.5 million people in the United States with three times the number of 
females affected than males.  It begins in women between the ages of 30 and 60, however, it 
appears in men much later in life (Dongxing et al, 2015).  Current medication has been helpful in 
treating to cooperate with rheumatoid arthritis, however, contain many harmful side effects such 
as stomach problems, internal bleeding, liver damage, and severe toxicity (Dongxing, et al, 
2015).  Current medication also does not provide a permanent cure. Bee venom therapy shows 
promising results as an alternative treatment option which might lead to a closer step to an 
effective treatment with further research. 
 It is commonly known that when a bee stings and delivers its venom, it results in the 
bee’s death.  This is due to the abdominal rupture which occurs when the bee is unable to pull 
out its barbed stinger. Thus it leaves behind its stinger, parts of its abdominal and digestive tract 
along with the associated muscles and nerves (Smart et al. 2017).  Therefore, extracting bee 
venom without causing mortality requires a special machine, a venom collection frame, which is 
designed to stimulate venom ejection without harm to the bee. The collection frame is composed 
of plates and a pulse generator which delivers minor electrical shocks, or sometimes generate 
specific sound frequencies which stimulate a sting reflex (Abrantes, et al 2017). An alarm odor 
from the venom that has been already ejected onto the glass sheet irritates neighboring bees to 
sting the glass and release additional venom.  Because the bee is not stinging a penetrable 
surface, the stinger remains intact with the abdomen, thus there is no harm to the bee.  Upon 
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completion, the bees are shaken off the device and the venom is scraped into a container to be 
immediately taken into a laboratory for processing and storage (Abrantes, et al 2017).  
Depending on the country, there are different rules and regulations around the storage of bee 
venom. For example, in Brazil, the moisture and protein contents are specified as well as the 
packaging type in order to preserve the efficacy and purity of the venom (Abrantes, et al 2017).   
 Bee venom therapy is an alternative to current conventional treatments for Rheumatoid 
Arthritis which include DMARDs, disease-modifying antirheumatic drugs such as leflunomide, 
hydroxychloroquine, methotrexate, sulfasalazine (Jae-Dong et al, 2005). Non-steroidal anti-
inflammatory agents (NSAIDs) and corticosteroids are also commonly used for treatment.  Bee 
Venom is produced by both worker bees and queen bees is composed of Mellitin, Apamin, 
Adolapin, enzymes such as Phospholipase A2 and hyluronidase (Jae-Dong et al, 2005).  It is 
because of this very unique peptide and protein composition of bee venom that individuals 
allergic to yellow jackets, wasps, and insects can still use bee venom as a treatment option (Jung 
et al, 2017).  
 To start with, Melittin is composed of 26 amino acids comprising 50% of bee 
venom.  This powerful cell lytic agent contains anti-inflammatory properties (Darwish et al. 
2013).  In a study conducted by Park and colleagues, researchers investigated the molecular 
mechanisms of the anti-arthritic effects of BV compared to Melittin.  In order to do this, 
researchers looked into the different components of RA inflammation: Prostaglandin (PGE2) 
production, Nitric Oxide (NO) production, expressions of inflammatory genes (COX-2, iNOS, 
cPLA2), and NF-kB DNA binding.  By observing the synoviocytes of Complete Freund’s 
Adjuvants (CFA) induced RA rat models, researchers found the average amount of PGE2 
production to be 5400 CPM (counts per minute) and the average NO generation to be 10 μM. 
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After being treated with BV, the PGE2 production decreased to by nearly 50% to 3000 CPM and 
the NO generation decreased to 3.9 μM (Park et al. 2004).  The synoviocytes treated with 
isolated Melittin also showed that PGE2 production decreased to 3200 CPM and the NO 
generation to 5 μM (Park et al. 2004).  This shows that Melittin does play a role in decreasing 
production of PGE2 and NO but the BV has a greater effect in decreasing 
these factors.  Researchers concluded that the other components of BV allow this greater result 
by possible synergistic interaction of Melittin and the other components (adolapin, apamin, etc.) 
(Park et al. 2004).   
            In another experiment, researchers looked at the effect of isolated Melittin compared to 
complete BV on the expression of inflammatory genes: cyclooxygenase-2 (COX-2), inducible 
nitric oxide synthase (iNOS), and cytosolic phospholipase A2 (cPLA2).  These inflammatory 
genes are highly expressed in the case of RA due to the chronic inflammation.  By using western 
blotting, researchers found that the expression of COX-2 decreased by 70% with BV and 80% 
with Melittin (Guastadisegni et al. 2002).  iNOS expression decreased by 60% with BV and 96% 
with Melittin while cPLA2  expression decreased by  30% with BV and 70% with Melittin. (This 
last result was probably due to BV already containing PLA2 as one of its components. Research 
is still being conducted on what the exact role PLA2 has in the anti-inflammatory process 
(Guastadisegni et al. 2002).  The transcription of these inflammatory genes is regulated by 
protein Nuclear Factor Kappa B (NF-kB).  To understand the role Melittin plays in the molecular 
mechanism of decreasing the expression of those genes, researchers experimented with exposing 
cells to tumor necrosis factor alpha (TNF-α) which activates NF-kB.  They found that Melittin 
reduces TNF-α activity by 57% (Guastadisegni et al. 2002).  They concluded that Melittin results 
in anti-inflammatory actions through a cascade of events starting with inhibiting TNF-α, which 
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can then no longer activate NF-kB, which in turn can no longer regulate the transcription of the 
inflammatory genes (Guastadisegni et al. 2002).  
            Another molecular mechanism of Melittin affecting NF-kB activity is examined when 
looking into the NF-kB DNA binding activity in terms of its various protein subunits.  In this 
experiment, researchers used an electrophoretic mobility shift assay (EMSA) on a nuclear extract 
of synoviocytes.  They found that Melittin significantly inhibited NF-kB subunits p50, p-IkB, 
and IkB based on their presence in intensity on the assay (Xie et al. 1999).  Researchers 
concluded that by inhibiting these subunits, NF-kB DNA binding activity is decreased and 
therefore there is decreased expression of the inflammatory genes triggered by NF-kB (Xie et al. 
1999).    
 Phospholipase A2 (PLA 2) makes up to10-12% of bee venom and is the main component 
responsible for causing anaphylactic shock in sensitive individuals (Putz et al, 2006).  However, 
PLA2 can stimulate production of regulatory T cells which play a role in suppressing 
inflammation and regulating immune response.  This is illustrated in an inflammation-induced 
rat model with three different treatments: 1% ovalbumin, control, and 1% ovalbumin with 
PLA2.  Compared to the control, there was an increased production (the highest amount out of 
the three treatments) of regulatory T cells by 12% in the rats treated with ovalbumin and PLA2 
(Park et al. 2016).  Regulatory T cells use additional suppressive strategies to resolve 
inflammation and limit tissue damage. The proposed mechanism model of regulatory T cell 
stimulation is that PLA2 binds to receptor CD206 of dendritic cells which increases COX-2 
expression and stimulates production of PGE2 (initially increasing inflammation in the short 
term).  PGE2 binds receptor EP2 promotes regulatory T cell differentiation.  This Treg cell 
secretes cytokine interleukin 10 (IL-10) which then suppresses inflammatory helper T cells (TH-
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1, TH2, TH17) (Lee et al. 2017).  Further research is being conducted to better understand the 
molecular mechanism of PLA2 , and whether it is better to include or isolate it out of BV for the 
treatment of RA.  
 Adolapin is a basic polypeptide which makes up 2% of bee venom and is believed to also 
have anti-inflammatory properties.  This characteristic is demonstrated in a study where rats with 
induced edema were treated with saline and 20μg/ml of adolapin followed by measuring the 
degree of inflammation of their hind paw using a tool called differential volumeter.  Results 
showed that the rats treated with the adolapin showed a 70% decrease in inflammation compared 
to the control (Shkenderov et al. 1997).  Adolapin shows another anti-inflammatory effect by 
inhibiting cyclooxygenase (COX) of the microsomes of rat spleens in a study conducted by 
Shkenderov and colleagues.  COX is responsible for the formation of prostaglandins that 
stimulate inflammation (Woo-Ram et al, 2009).  In this study, researchers pre-incubated 
microsomes with 1.5μg/ml Adolapin and noted the COX activity of the microsomes by 
spectrophotometer assay.  Shkenderov and colleagues found that microsomes treated with 
Adolapin illustrated inhibition of COX activity by 85% (Shkrenderov et al. 1997).  By inhibiting 
cyclooxygenase, the prostaglandins involved in the chronic inflammation are also subsequently 
inhibited (Woo-Ram et al, 2009).  Adolapin may also show analgesic properties.  In a study 
conducted by Michailova and colleagues, they measured peritoneal contractions in groups of 
mice after intraperitoneal injections of one group receiving 0.1ml of 3% acetic acid and another 
group receiving 0.3 μg prostaglandin E1 in 0.1ml of saline. These non-control groups were 
injected with either 20 or 50 μg/kg adolapin 30 minutes before the irritants. By observing the 
peritoneal contractions, they noted a 60 to 80% inhibition of irritation in the adolapin treated 
groups (Michailova et al. 2002).  Researchers concluded that this could be due to possible 
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analgesic effect more research is needed and being conducted to better understand the exact anti-
inflammatory role and analgesic mechanism of Adolapin in treating RA.   
  Hyaluronidase and Apamin are the two final discussed components of BV.  
Although their therapeutic properties are suggested, there is not as much research conducted in 
these protein compositions as the ones already mentioned.  Hyaluronidase makes 2% of bee 
venom and is responsible for catalyzing hyaluronic acid via a hydrolysis reaction (Masuda et al, 
2010).  This enables the bee venom to embed itself into tissues by increasing cellular 
permeability and increasing blood circulation.  Apamin is a peptide of 18 amino acids and 
comprises 3% of bee venom (Gauldie et al, 2006).  This peptide is responsible for blocking 
potassium channels activated by calcium ions, which normally contributes to the painful 
sensation felt by an individual stung by a bee.  However, in repeated dosages and treatments of 
bee venom therapy, Apamin was shown to stimulate the central nervous system (CNS) and the 
peripheral nervous system (PNS) so that central and peripheral pain threshold increased (Woo-
Ram et al, 2009). This change consequently decreased the sensation of pain for individuals with 
Rheumatoid Arthritis.  This anti-inflammatory biologically active peptide also preserves 
erythrocytes, stimulates cortisone release, and increases the body’s defense capacity (Woo-Ram 
et al, 2009).  Research is still being conducted and the future research will address actual animal 
models to better understand the exact role and molecular mechanism of these two proteins.    
In the case of treating Rheumatoid Arthritis (RA), the beneficial effects of BV reduce 
stiffness and pain in joints and contribute to other pharmacological actions through 
immunomodulation. BV has been shown to block the synthesis of pro-inflammatory substances 
such as cytokinine, TNF-2 and the COX-2 enzyme.  BV also inhibits the spread of rheumatoid 
synovial cells (Darwish et al, 2013). One study indicated that BV directly counteracts the 
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inflammatory effects of cigarette smoke condensate (CSC) in a subject afflicted with RA – 
confirming the anti-inflammatory effects of BV (Darwish et al, 2013). Another study has 
demonstrated that “BV injection into the Zusanli acupoint has both anti-inflammatory and anti-
nociceptive effects on Freund’s adjuvant-induced arthritis in rats” (Hyun-Woo et al, 2005). The 
healing properties of BVT have been scientifically demonstrated. Based on the strength of the 
medical evidence, it can be said that a combined application of traditional medication and bee 
venom therapy is more effective than the simple use of medication to alleviate rheumatoid 
arthritis (Hyun-Woo et al, 2005). This was shown in a study where adjuvant induced arthritis in 
rats was treated with either methotrexate alone or a combination of methotrexate and bee venom. 
Not only was the latter combination more effective in reducing arthritic inflammation, it also 
reduced the hepatoxicity of the methotrexate by one third (Young-Bae et al, 2002).  Given the 
long term use of BVT in both traditional Eastern medicine and now in the West in the last 
hundred years, the positive benefits need to be further explored and systematized into new 
treatment plans to benefit the sufferers of RA (Hyun-Woo et al, 2005).  
BVT can also provide better results in combination therapy with current medication.  In a 
study conducted by Darwish and colleagues, 50 male wistar rats (Rattus rattus) were injected 
with Complete Freund’s Adjuvants (CFA) which induced RA (Darwish et al. 2013).  They were 
divided into 5 groups: one control group (only CFA), one group was given saline, one group was 
given methotrexate (standard DMARD), one group was given BV injections, and the last group 
was given both methotrexate and BV injections (Darwish et al. 2013).  After 21 days of 
observation following the various treatments, results were measured in terms of the amount of 
cytokine TNF-α and expression of the NF-kb signal pathway (both play major role in systemic 
inflammation therefore expressed in all rats with CFA).  Methotrexate treated rats were shown to 
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decrease expression of NF-kb by 30% but there was not a significant reduction in TNF-α.  Rats 
treated with BV injections showed a 50% reduction in expression of NF-kb and a 30% reduction 
in TNF-α (Darwish et al. 2013).  However, the combined treatment of both methotrexate and BV 
injections showed a 67% reduction in TNF-α and 71% reduction in NF-kb expression.  In 
conclusion, although BV injections reduced swelling more than the methotrexate treatment, 
combining both treatments, BV injections and methotrexate, shows a combined greater 
beneficial effect in reducing the factors of inflammation (Darwish et al. 2013). 
Rheumatoid arthritis is a debilitating autoimmune disease with millions of sufferers 
across the globe (Cooney et al, 2011). Traditional treatments with steroids, immunosuppressant 
and anti-inflammatory drugs can offer only temporary relief from the pain, while the use of the 
drugs themselves can have negative side-effects which cause their own health issues. The 
exploration of BVT by Western scientific methods is a beneficial step in proving the efficacy of 
this traditionally Eastern medical treatment. With the clear anti-inflammatory benefits of a 
measured systematic treatment plan without the harmful side-effects of current medications, the 
applications of BVT seem promising in creating the means to safely alleviate the symptoms of 
RA as well as many other autoimmune diseases. 
Altogether more research needs to be done on the individual BV components to 
determine which one is more beneficial for the treatment of RA.  Whether it is primarily Melittin 
or the addition of the other isolated peptides such as Adolapin or phospholipase A2 which 
promise to provide the most effective means for alleviating arthritis symptoms still remains to be 
seen. The full mechanisms of BVT require further studies and trials in order to be fully 
understood and applied with the greatest efficacy. 
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